Form 8-K - Current report:
SEC Accession No. 0001193125-25-119447
Filing Date
2025-05-14
Accepted
2025-05-14 08:53:50
Documents
15
Period of Report
2025-05-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d943903d8k.htm   iXBRL 8-K 25635
2 EX-2.1 d943903dex21.htm EX-2.1 33509
3 EX-99.1 d943903dex991.htm EX-99.1 16025
  Complete submission text file 0001193125-25-119447.txt   209556

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA blue-20250513.xsd EX-101.SCH 2862
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE blue-20250513_lab.xml EX-101.LAB 17235
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE blue-20250513_pre.xml EX-101.PRE 10820
17 EXTRACTED XBRL INSTANCE DOCUMENT d943903d8k_htm.xml XML 3503
Mailing Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145
Business Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145 339-499-9300
bluebird bio, Inc. (Filer) CIK: 0001293971 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35966 | Film No.: 25942948
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)